Literature DB >> 12975598

New approaches to overcome tolerance to nitrates.

Michael Schwemmer1, Eberhard Bassenge.   

Abstract

In isolated cells (vascular smooth muscle, endothelium, platelets), perfused hearts, in vivo experiments, conscious instrumented animals, and in human subjects the induction of tachyphylaxis and tolerance to various exogenous NO-donors was analyzed. Various ways to circumvent tolerance were successfully tested. Different nitrovasodilators were associated with different rates and magnitudes of generation of tolerance and reactive oxygen radicals (ROS) in all models tested, beginning with PETN (pentaerithrityltetranitrate) (lowest rate) and concluding with GTN (highest rate). This pattern was found in all models tested (isolated cells, perfused organs, and in vivo experiments). The observed changes in ROS production in isolated cells were identical to changes in ROS production in vascular smooth muscle, endothelial cells, and platelets. Thus, blood cells such as washed platelets could be used as marker cells to identify induction of tolerance and rise in platelet activity, closely reflecting changes in the rate of tolerance generation to nitrates associated with enhanced oxidant stress (ROS generation). Generation of tachyphylaxis could be suppressed or even avoided by supplementation of appropriate antioxidants (SOD, vitamin C, DMSO, beta-blockers with antioxidant capacity, modulators of prostanoid metabolism such as ASS) in all models tested, including human subjects. Even fully developed tolerance (during non-intermittent GTN-administration) could be reversed by starting an appropriate antioxidant supplementation. This indicates that other potential factors involved in the generation of nitrovasodilator-associated tolerance (reducing the intended vasodilation and the concovactent decreases in blood pressure, namely augmented sympathetic and RAS-activity, changes in the activity of soluble guanylyl cyclase, protein kinase C, phosphodiesterase, etc.) are of minor importance. Thus, the treatment of tolerance under clinical conditions should closely target changes in redox potential and antioxidant capacity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975598     DOI: 10.1023/a:1025343919959

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  6 in total

1.  Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.

Authors:  P Wenzel; U Hink; M Oelze; A Seeling; T Isse; K Bruns; L Steinhoff; M Brandt; A L Kleschyov; E Schulz; K Lange; H Weiner; J Lehmann; K J Lackner; T Kawamoto; T Münzel; A Daiber
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

Review 2.  Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

Authors:  Matthias Oelze; Swenja Schuhmacher; Andreas Daiber
Journal:  Exp Diabetes Res       Date:  2010-12-27

3.  Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

Authors:  Bobby Nossaman; Edward Pankey; Philip Kadowitz
Journal:  Crit Care Res Pract       Date:  2012-02-28

4.  Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.

Authors:  Hanke Mollnau; Philip Wenzel; Matthias Oelze; Nicolai Treiber; Andrea Pautz; Eberhard Schulz; Swenja Schuhmacher; Kurt Reifenberg; Dirk Stalleicken; Karin Scharffetter-Kochanek; Hartmut Kleinert; Thomas Münzel; Andreas Daiber
Journal:  BMC Cardiovasc Disord       Date:  2006-11-08       Impact factor: 2.298

5.  Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains.

Authors:  Rana Rehan Khalid; Muhammad Tahir Ul Qamar; Arooma Maryam; Ayesha Ashique; Farooq Anwar; Mohammed H Geesi; Abdul Rauf Siddiqi
Journal:  Molecules       Date:  2018-08-25       Impact factor: 4.411

6.  The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation.

Authors:  Sebastian Steven; Matthias Oelze; Michael Hausding; Siyer Roohani; Fatemeh Kashani; Swenja Kröller-Schön; Johanna Helmstädter; Thomas Jansen; Christine Baum; Marc Iglarz; Eberhard Schulz; Thomas Münzel; Andreas Daiber
Journal:  Oxid Med Cell Longev       Date:  2018-12-27       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.